Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin

A model for ascending unobstructed urinary tract infection was developed in mice to study the pathogenesis of urinary tract infection induced by Escherichia coli associated with urinary tract infection in humans. Specifically, the model was designed to monitor the initial stages of the infectious process, e.g., bacterial adhesion. Mice were selected since the specificity and intensity of bacterial attachment of pyelonephritogenic E. coli strains to human and mouse uroepithelial cells were similar. Female mice were infected by urethral catheterization and installation of bacteria in the urinary bladder. To maximize clearance of unattached bacteria, no obstructive manipulations were performed. After sacrifice, the persistence of bacteria in kidneys and bladder was determined by viable counts on homogenized tissues. The experimental infection was standardized by using one pyelonephritis (HU734) and one normal fecal (414) E. coli isolate. With both strains all of the bladders became infected, but E. coli 414 was eliminated more rapidly than HU734. The percentage of positive kidney cultures increased with the bacterial inoculum concentration and volume. An inoculum of 0.05 ml containing 10(10) bacteria per ml was selected, giving the highest percentage of positive kidney cultures without detectable bacterial spread to the blood stream. The variation in the percentage of positive kidney cultures possibly depended on the degree of vesicoureteric reflux in the individual animals. Both in the kidneys and in the urinary bladders, strain HU734 yielded higher numbers of bacteria at 24 h and persisted longer than did strain 414. Several E. coli pyelonephritis isolates with properties associated with virulence in the human urinary tract consistently were recovered from mouse kidneys and bladders in higher numbers than E. coli strains of human fecal origin lacking those properties. The role of bacterial adhesion per se is the topic of the accompanying paper.

[1]  S. Falkow,et al.  Contribution of Adhesion to Bacterial Persistence in the Mouse Urinary Tract , 1983, Infection and immunity.

[2]  G. Schoolnik,et al.  Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue , 1982, Nature.

[3]  R. Möllby,et al.  OCCURRENCE OF P-FIMBRIATED ESCHERICHIA COLI IN URINARY TRACT INFECTIONS , 1981, The Lancet.

[4]  L. Hagberg,et al.  Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections , 1981, Infection and immunity.

[5]  H. Leffler,et al.  Chemical identification of a glycosphingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes , 1980 .

[6]  W. J. Tuddenham,et al.  Pseudomonas urinary tract infection in mice , 1980, Infection and immunity.

[7]  I. Snyder,et al.  Mannose-sensitive interaction of Escherichia coli with human peripheral leukocytes in vitro , 1979, Infection and immunity.

[8]  N. Sharon,et al.  Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside. , 1979, The Journal of infectious diseases.

[9]  K. Tsuchiya,et al.  Experimental urinary tract infection with Pseudomonas aeruginosa in mice , 1978, Infection and immunity.

[10]  U. Lindberg,et al.  Adhesion to normal human uroepithelial cells of Escherichia coli from children with various forms of urinary tract infection. , 1978, The Journal of pediatrics.

[11]  E. Balish,et al.  Effect of immunization of bacterial adherence to urothelium. , 1978, Investigative urology.

[12]  M. Sarvas,et al.  Effect of polymyxin on the ultrastructure of the outer membrane of wild-type and polymyxin-resistant strain of Salmonella , 1976, Journal of bacteriology.

[13]  R. Wilson,et al.  Modified thiocarbohydrazide procedure for scanning electron microscopy: routine use for normal, pathological, or experimental tissues. , 1975, Stain technology.

[14]  F. Silverblatt HOST-PARASITE INTERACTION IN THE RAT RENAL PELVIS , 1974, The Journal of experimental medicine.

[15]  H. Smith,et al.  Observations on the pathogenic properties of the K88, Hly and Ent plasmids of Escherichia coli with particular reference to porcine diarrhoea. , 1971, Journal of medical microbiology.

[16]  C. Norden,et al.  Antibacterial mechanisms of the urinary bladder. , 1968, The Journal of clinical investigation.

[17]  G. M. Gray,et al.  The carbohydrate structures of the neutral ceramide glycolipids in kidneys of different mouse strains with special reference to the ceramide dihexosides. , 1968, Chemistry and physics of lipids.

[18]  W. Keane,et al.  Experimental pyelonephritis. XIV. Pyelonephritis in normal mice produced by inoculation of E. coli into the bladder lumen during water diuresis. , 1967, The Yale journal of biology and medicine.

[19]  E. Mårtensson Neutral glycolipids of human kidney isolation, identification, and fatty acid composition. , 1966, Biochimica et biophysica acta.

[20]  R. Heptinstall EXPERIMENTAL PYELONEPHRITIS. BACTERIOLOGICAL AND MORPHOLOGICAL STUDIES ON THE ASCENDING ROUTE OF INFECTION IN THE RAT. , 1964, Nephron.

[21]  R. Cotran,et al.  Retrograde Proteus pyelonephritis in rats. Bacteriologic, pathologic and fluorescent-antibody studies. , 1963, The American journal of pathology.

[22]  Clair E. Cox,et al.  Experiments with induced bacteriuria, vesical emptying and bacterial growth on the mechanism of bladder defense to infection. , 1961, The Journal of urology.

[23]  B. Andersen,et al.  PYELITIS, AN IMPORTANT FACTOR IN THE PATHOGENESIS OF RETROGRADE PYELONEPHRITIS , 1961, The Journal of experimental medicine.

[24]  G. Meynell The applicability of the hypothesis of independent action to fatal infections in mice given Salmonella typhimurium by mouth. , 1957, Journal of general microbiology.

[25]  A. P. Shapiro,et al.  Hematogenous pyelonephritis in rats. I. Its pathogenesis when produced by a simple new method. , 1955, The Journal of clinical investigation.